29.7.2022
Background Glioblastoma multiforme represents approximately half of the cases of central nervous system malignant tumors. The median age at diagnosis is 64 years, and the incidence was reported to be approximately 3 cases in 100 000 people. Genetic conditions, such as Li Fraumeni and Lynch Syndrome, are associated with a…
Articles
31.5.2022
Helsinki, 31st of May, 2022 - MVision AI announces that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for guideline-based, AI-powered software for automatic segmentation for radiotherapy. (more…)
News, Press Releases
24.3.2022
Colorectal cancer (CRC) is one of the most common types of cancer diagnosed in the UK. About 41,000 people get cancer in the large bowel each year in the UK. In 2020, the WHO reported that colorectal cancer accounted for 10% of the cancers diagnosed annually. (Global Cancer Observatory) This…
24.2.2022
Machine learning has become vital to the modern world, turning data into real, actionable insights. In radiotherapy, there has been a continuous increase in patient-specific needs met with the help of artificial intelligence, from quality personalized treatment to medical imaging. In the machine learning field, there are two main types…
News
7.1.2022
According to the NHS, breast cancer is the most common type of cancer in the UK. Roughly 1 in 8 women are diagnosed with breast cancer during their lifetime. However, there is a good chance of recovery if the cancer is detected early. (NHS) The World Health Organization estimates that…
29.12.2021
2021 is an innovative and foundational year for MVision AI. We are proud of what we have accomplished so far and super excited about what is in store for us in the future. One feeling that stands out as we look back at 2021 is gratitude. We thank everyone who…
3.12.2021
60-70% of cancer patients receive some type of radiation therapy. For some cancers, radiation therapy alone is an effective treatment. The purpose of radiotherapy is to destroy cancer cells and slow tumor growth while limiting the harm to nearby healthy tissue. When it is not possible to destroy all of…
24.11.2021
Stereotactic body radiotherapy (SBRT), or stereotactic ablative body radiotherapy (SABR), is an innovative radiation therapy technique. The technique uses special equipment to precisely deliver a dose of radiation to a tumor. SBRT aims to employ the highest possible dose of radiation to kill cancer while minimizing damage to surrounding tissues…
5.11.2021
Helsinki - 5th of November, 2021 - MVision AI, the pioneer of SaaS radiotherapy treatment planning optimization, announces their distribution partnership YourRad AB, the prime supplier of radiation treatment products for Nordic Clinics. The commitment authorizes YourRad AB with the entitlement to distribute products and services of MVision AI in…
Press Releases
8.10.2021
Since the invention of the world's first web server in 1989, servers have shaped our society and technology today. In 2020 alone, the global server market revenues reached over 91 billion USD, with 12.15 million server shipments worldwide. The fact that you can read this from your laptop, PC, MAC,…
29.9.2021
Helsinki - 29th of September 2021 - MVision AI, the leading service provider of guideline compliant radiotherapy software, announces a new distribution partnership with AQUILAB, the chief provider of revolutionary oncology software solutions throughout France. (more…)
21.9.2021
September is Uterine Cancer Awareness Month. Raising awareness is very close to the MVisionaries since uterine cancer is the fourth most common cancer for women. It is estimated that 66,570 people in the United States alone will be diagnosed with uterine cancer this year. 90% of uterine cancers are endometrioid…
Subscribe to get information, latest news and other interesting offers about MVision AI